Scotland · NHS Scotland MSAN
Disopyramide (Rythmodan Retard®) 250mg modified-release tablets and
MSAN(2024)41 · Level 2 · issued 05 Jul 2024
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Disopyramide (Rythmodan Retard®) 250mg modified-release tablets are out of stock until mid | Out of stock | mid |
| 2. Disopyramide (Rythmodan®) 100mg capsules will be out of stock from mid-July 2024 until mid | Out of stock | mid |
| 4. Alternative treatments to disopyramide remain available (see Additional information). | Available | — |
| 6. Unlicensed specials of disopyramide 25mg/5ml & 50mg/5ml oral suspension are available, lead | Available | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2024:41
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
41503ef7676ceede45bd9a1ae3e5d9aac327f2264d75fc9200d037a723a1b817sha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2024-41.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.